NXTC makes replay available for event on cancer drug trial data

June 4, 2026 8:01 AM

NextCure Inc. (NASDAQ: NXTC) announced that a replay of its virtual key opinion leader event discussing SIM0505 trial data is ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found